We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

158 hedge funds and large institutions have $539M invested in Anika Therapeutics in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 59 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

75.25% more ownership

Funds ownership: 0% → 75.25% (+75%)

36% more call options, than puts

Call options by funds: $1.08M | Put options by funds: $796K

2% more capital invested

Capital invested by funds: $529M → $539M (+$10.2M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 59

3% less funds holding

Funds holding: 163 → 158 (-5)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

Holders
158
Holders Change
-5
Holders Change %
-3.07%
% of All Funds
3.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
57
Reduced
59
Closed
19
Calls
$1.08M
Puts
$796K
Net Calls
+$284K
Net Calls Change
+$1.01M

Top Buyers

Rank Fund Capital Flow
1
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management
California
+$16M
2
BFA
BlackRock Fund Advisors
California
+$6.34M
3
NAP
New Amsterdam Partners
New York
+$2.57M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$2.49M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.98M

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$8.19M
2
Millennium Management
Millennium Management
New York
-$6.91M
3
TSW
Thompson Siegel & Walmsley
Virginia
-$4.4M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.41M
5
SFM
Systematic Financial Management
New Jersey
-$2.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MFS
151
MSI Financial Services
Massachusetts
$6K +$2.31K +50 +79%
EF
152
Empirical Finance
Pennsylvania
$6K +$4.86K +105 New
Loomis, Sayles & Company
153
Loomis, Sayles & Company
Massachusetts
$4K – – –
TWA
154
TCI Wealth Advisors
Arizona
$1K – – –
NI
155
Numeric Investors
Massachusetts
– -$8.19M -171,090 Closed
SFM
156
Systematic Financial Management
New Jersey
– -$2.4M -50,200 Closed
Arrowstreet Capital
157
Arrowstreet Capital
Massachusetts
– -$1.28M -26,721 Closed
DC
158
Deere & Company
Illinois
– -$1.17M -24,440 Closed
BIM
159
Bogle Investment Management
Massachusetts
– -$1.08M -22,629 Closed
GCP
160
GSA Capital Partners
United Kingdom
– -$982K -20,520 Closed
JIM
161
Jupiter Investment Management
United Kingdom
– -$901K -18,841 Closed
ADEF
162
Adams Diversified Equity Fund
Maryland
– -$483K -9,000 Closed
AP
163
AHL Partners
United Kingdom
– -$369K -7,721 Closed
RG
164
Renaissance Group
Kentucky
– -$306K -6,397 Closed
CEP
165
Chicago Equity Partners
Illinois
– -$294K -6,150 Closed
QIM
166
Quantitative Investment Management
Virginia
– -$272K -5,700 Closed
UBS AM
167
UBS AM
Illinois
– -$263K -5,500 Closed
CAM
168
Capstone Asset Management
Texas
– -$228K -4,760 Closed
CCMH
169
Cornerstone Capital Management Holdings
New York
– -$215K -4,500 Closed
BFM
170
Boothbay Fund Management
New York
– -$206K -4,298 Closed
Simplex Trading
171
Simplex Trading
Illinois
– -$58.6K -1,267 Closed
PCM
172
Prelude Capital Management
New York
– -$51K -1,067 Closed
Bessemer Group
173
Bessemer Group
New Jersey
– -$20K -412 Closed
AA
174
AlphaMark Advisors
Kentucky
– +$139 +3 New
AssetMark Inc
175
AssetMark Inc
California
– +$370 +8 New
3 4 5 6
7

ANIK Hedge Fund Activity: Q4 2016 in Review

158 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2016, worth a combined $539M — up 1.9% from $529M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of ANIK and 16 opened new positions — a net loss of 3 holders — while 59 trimmed existing stakes and 57 added.

The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $16M. The largest seller was Numeric Investors, exiting entirely with an estimated $8.19M sold.

  • 158 institutional investors held Anika Therapeutics (ANIK) as of Q4 2016, down from 163 in Q3 2016.
  • Funds reported $539M of Anika Therapeutics stock for Q4 2016, up 1.9% quarter-over-quarter.
  • 16 funds opened new Anika Therapeutics positions in Q4 2016 and 19 closed out, a net change of -3 holders.
  • The largest Anika Therapeutics buyer in Q4 2016 was Kayne Anderson Rudnick Investment Management, an estimated $16M added.
  • The largest Anika Therapeutics seller in Q4 2016 was Numeric Investors, an estimated $8.19M sold.

Based on aggregated 13F filings for Q4 2016.